This article is more than 5 years old. Information may no longer be current.

Bausch & Lomb completes acquisition of eyeonics

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ROCHESTER, N.Y. — Bausch & Lomb has completed its acquisition of eyeonics, manufacturer of the accommodating IOL crystalens, according to a press release from the company.

Eyeonics is now a wholly owned subsidiary of Bausch & Lomb, and the crystalens IOL adds to Bausch & Lomb's portfolio of ophthalmic surgical products for cataract, vitreoretinal and refractive markets, the release said.

Nixon Peabody LLP acted as legal counsel to Bausch & Lomb. Wilson Sonsini Goodrich & Rosati acted as legal counsel to eyeonics. Piper Jaffray & Co. served as a financial advisor to eyeonics.

Financial terms of the transaction have not been disclosed.